This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

GPS-like system shows promise as HIV vaccine strategy to elicit critical antibodies

GPS-like system shows promise as HIV vaccine strategy to elicit critical antibodies
Graphical abstract. Credit: Cell Host & Microbe (2024). DOI: 10.1016/j.chom.2024.04.006

A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.

Publishing in the journal Cell Host & Microbe, the study describes an approach that provides step-by-step directions for the to generate the elusive, yet necessary for a successful HIV vaccine.

"HIV is the fastest-evolving virus known. So it's been a long-standing goal in HIV research to create a vaccine that can generate broadly neutralizing antibodies that can recognize diverse HIV strains," said lead author Kevin Wiehe, Ph.D., associate professor in the Department of Medicine at Duke University School of Medicine and director of research at DHVI.

Wiehe and colleagues started with an engineered version of a broadly neutralizing antibody in its original state, before any mutations occurred. Knowing that the antibody will need to mutate to keep up with the ever-changing HIV virus, the researchers then added sequential mutations one-by-one to determine which were essential for the antibody to broadly neutralize HIV.

Doing this allowed them to figure out what the exact points were along the route to arrive at broadly neutralizing antibodies. They then developed a vaccine which gave the immune system the turn-by-turn directions to follow that mutational route.

Using mice specially bred to encode for the original version of the antibody, the researchers demonstrated that the guidance system approach triggered the immune system to start churning out the sought-after antibodies.

"This paper shows that our mutation-guided vaccine strategy can work," said Wiehe, adding that the technique could also be used in vaccines for other diseases. "This strategy potentially gives us a way to design vaccines to direct the immune system to make any antibody we want, which could be a broadly neutralizing antibody for all coronavirus variants, or an anti-cancer antibody."

Wiehe said the next challenge will be to reproduce the study in primates and then humans.

More information: Kevin Wiehe et al, Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction, Cell Host & Microbe (2024). DOI: 10.1016/j.chom.2024.04.006

Journal information: Cell Host & Microbe
Provided by Duke University
Citation: GPS-like system shows promise as HIV vaccine strategy to elicit critical antibodies (2024, May 9) retrieved 23 June 2024 from https://medicalxpress.com/news/2024-05-gps-hiv-vaccine-strategy-elicit.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

HIV vaccine takes step forward with confirmation of neutralizing antibodies

12 shares

Feedback to editors